logo

For the Inventor, By the Inventor

Madison, WI, United States of America

Cellectar Biosciences, Inc.


USPTO Granted Patents = 10



Forward Citations = 27

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Jamey Paul Weichert (8 out of 45 patents)

silverMedal Anatoly Pinchuk (8 out of 30 patents)

bronzeMedal Marc Longino (8 out of 20 patents)

4.  Chorom Pak (5 out of 7 patents)

5.  Kevin Kozak (5 out of 5 patents)

6.  Joseph J Grudzinski (4 out of 6 patents)

7.  Benjamin Titz (4 out of 5 patents)

8.  Nathan Stehle (4 out of 4 patents)

9.  Jarrod Longcor (2 out of 2 patents)

10.  Irawati Kandela (1 out of 5 patents)

11.  William R Clarke (1 out of 7 patents)


10 patents:

1. 12503479 - Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy (2025-12-23),
2. 12496346 - Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy (2025-12-16),
3. 11467159 - Luminescent phospholipid analogs for the identification and isolation of circulating tumor cells (2022-10-11),
4. 11439709 - Phospholipid ether analogs as cancer-targeting drug vehicles (2022-09-13),
5. 9925269 - Phospholipid ether analogs as cancer-targeting drug vehicles (2018-03-27),
6. 9616140 - Fluorescent phospholipid ether compounds, compositions, and methods of use (2017-04-11),
7. 9579406 - Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof (2017-02-28),
8. 9550002 - Phospholipid analogs as diapeutic agents and methods thereof (2017-01-24),
9. 9480754 - Phospholipid ether analogs as cancer-targeting drug vehicles (2016-11-01),
10. 9345718 - Phospholipid ether analogs as cancer-targeting drug vehicles (2016-05-24),
Company Overview
Cellectar Biosciences, Inc. is a biotechnology company based in Madison, Wisconsin, focused on developing innovative therapies for cancer treatment. The company specializes in the discovery and commercialization of targeted phospholipid drug conjugates (PDCs), which are designed to selectively deliver therapeutic agents to cancer cells while minimizing effects on healthy tissues. Cellectar's research emphasizes enhancing the efficacy and safety of cancer therapies, aiming to improve patient outcomes in oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Cellectar Biosciences, Inc. USPTO Patent Assignee Logo
10 Patents

#68 in Madison, WI

#668 in Wisconsin

#29,866 in US

#56,047 in the World

Madison, WI (US)
Madison, WI, United States of America

Cellectar Biosciences, Inc.

Forward Citations = 27

11 inventors:

goldMedal Jamey Paul Weichert (8 out of 45 patents)

silverMedal Anatoly Pinchuk (8 out of 30 patents)

bronzeMedal Marc Longino (8 out of 20 patents)

4.  Chorom Pak (5 out of 7 patents)

5.  Kevin Kozak (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cellectar Biosciences, Inc.. Retrieved from https://idiyas.com/company/cellectar-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…